Latest public archive

FDA signals through April 30, 2026.

The public archive runs roughly two weeks behind the live monitor. Same-day source hits belong in the future Live Desk, not on the free site.

Public cutoff

Published window:
April 17 through April 30, 2026.

Why delayed:
Delay preserves premium value and gives us time to group source records into useful themes.

Live Desk later

Paid users should get same-day feed, search, alerts, filters, and export. Public readers get the slower archive and articles.

Warning letters

Apr 30
CareFusion 213, LLCDevices

FDA warning-letter record. Public source review points to device-quality monitoring as the relevant lane.

device qualitywarning letter

FDA source link

Recall and enforcement signals

Apr 29
Leading Pharma, LLCDrug recall

Class II recall signal tied to CGMP deviation wording and N-nitroso-Furosemide above recommended intake limits.

CGMPimpuritydrug recall

FDA source link

Apr 29
B. Braun Medical Inc.Drug recall

Class II recall signal tied to lack-of-sterility-assurance language and possible leakage after foil removal.

sterility assurancepackaging

FDA source link

Apr 29
Medline Industries, LPDevice recall

Class II recall signal tied to unapproved design changes outside 510(k) clearance.

device quality510(k)design change

FDA source link

Apr 29
Olympus Corporation of the AmericasDevice recall

Class II recall signal tied to potential detachment of a distal tip component during use.

device componentrecall signal

FDA source link